Clover has fully integrated biopharmaceutical drug manufacturing capabilities.

Our pilot GMP-compatible manufacturing facility in Chengdu has 350L in upstream bioreactor capacity to support preclinical research, IND-enabling and Phase I drug material. 

We have completed construction of our GMP manufacturing facility with 2 x 2,000L upstream single-use bioreactor capacity to support late-stage clinical trials and commercialization for multiple products.